期刊文献+

NADPH氧化酶在常见心血管疾病中的表达与作用 被引量:5

The expression and function of NADPH oxidase in common cardiovascular diseases
下载PDF
导出
摘要 NADPH氧化酶是唯一一类以生成活性氧类物质为主要功能的酶类,目前共发现7种亚型,心血管系统表达其中4种。NADPH氧化酶参与心脏和血管生理与病理过程的调节,如细胞增殖、迁移、细胞肥大、凋亡和细胞外基质重构等。本文较系统的综述NADPH氧化酶在常见心血管疾病包括心力衰竭、冠心病、高血压病和心律失常中的表达与作用,以期为临床抗氧化治疗提供帮助。 The NADPH oxidase (Nox) is the only known enzyme with the sole function to produce reactive oxygen species (ROS). Seven family members have been identified, and four of them are expressed in the cardiovascular system. Nox perform an important role in regulation of the physical and pathological process in cardiovascular system, such as cell proliferation, migration, cell hypertrophy, apoptosis and remodeling of extracellular matrix. Here we review the recent progress in the expression and function of Nox in common cardiovascular diseases, including heart failure, coronary heart disease, hypertension and cardiac arrhythmia, thus to provide some help for clinical antioxidant therapy.
作者 王梦龙 万军
出处 《中国医药导报》 CAS 2015年第26期34-38,共5页 China Medical Herald
基金 国家自然科学基金(81170208 30871050) 湖北省自然科学基金(2007ABA208)
关键词 NADPH氧化酶 心血管疾病 氧化应激 抗氧化治疗 NADPH oxidase Cardiovascular disease Oxidative stress Antioxidant therapy
  • 相关文献

参考文献50

  • 1BurgoyneJR, Mongue-Din H, Eaton P, et al. Redox signal?ing in cardiac physiology and pathology[J]. Circ Res, 20 12, 111(8): 1091-1106.
  • 2Cook NR,Albert CM,GazianoJM,et al, A randomized facto?rial trial of vitamins C and E and beta carotene in the sec?ondary prevention of cardiovascular events in women: re?sults from the Women's antioxidant cardiovascular study[J]. Arch Intern Med,2007, 167(15): 1610-1618.
  • 3Sesso HD, BuringJE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study. II randomized controlled trial[J].JAMA,2008 ,300(18): 2123-2133.
  • 4Finkel T. Oxidant signals and oxidative stress[J]. Curr Opin Cell Biol,2003, 15(2) :247-254.
  • 5Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure[J].J Clin Invest, 2005, 115( 3) : 500-508.
  • 6Zhang M,Perino A,Ghigo A,et al. NADPH oxidases in heart failure: poachers or gamekeepers?[J]. Antioxid Redox Signal, 2013,18(9): 1024-1041.
  • 7Akki A,Zhang M,Murdoch C,et al. NADPH oxidase sig?naling and cardiac myocyte function[J].J Mol Cell Cardi- 01,2009,47(1): 15-22.
  • 8KurodaJ, Ago T, Matsushima S, et al. NADPH oxidase 4 (Nox4 )is a major source of oxidative stress in the failing heart[J]. Proc Natl Acad Sci USA,2010, 107(35): 15565- 15570.
  • 9Heymes C,BendallJK,Ratajczak P,et al, Increased myocar?dial NADPH oxidase activity in human heart failure[J].J Am ColI Cardiol, 2003 ,41 (12): 2164-2171.
  • 10Maack C, Kartes T , Kilter H, et al. Oxygen free radical re?lease in human failing myocardium is associated with in?creased activity of racl-GTPase and represents a target for statin treatment[J]. Circulation, 2003 , 108 ( 13 ) : 1567- 1574.

同被引文献46

  • 1赵伟,孙国志,李荣侠,霍继明.沙棘总黄酮对糖尿病心脏病大鼠心肌细胞Bax、Bcl-2蛋白表达的影响[J].中国比较医学杂志,2007,17(8). 被引量:2
  • 2PEREZ-VIZCAINO F, DUARTE J. Flavonols and cardiovasculardisease[ J]. Mol Aspects Med, 2010,31(6):478 -494.
  • 3VAN GAAL LF, MERTENS IL,DE BLOCK CE. Mechanismslinking obesity with cardiovascular disease [J]. Nat, 2006,444(7121) :875 -880.
  • 4BHATIA LS,CURZEN NICHOLAS P, CALDER PHILIP C.Non-alcoholic fatty liver disease : a new and important cardiovas-cular risk factor. [ J ]. Eur Heart J, 2012,33 ( 10): 1190 -1200.
  • 5JAY N, COHN MD. Prevention of cardiovascular disease [ J].Trends Cardiovas Med, 2015 ,25 (5 ) : 436 -442.
  • 6NILSSON J, LICHTMAN A,TEDGUI A. Atheroprotective im-munity and cardiovascular disease : therapeutic opportunities andchallenges[ J] . J Intern Aferf,2015 ,278(5) : 507 - 519.
  • 7AHRENS I,LIP GREGORY YH,PETER K. New oral anticoag-ulant drugs in cardiovascular disease [ J ]. Thromb Haemost,2010,104(1) : 49 -60.
  • 8ARSENAULT KA, HIRSH J, WHITLOCK RP. Direct thrombininhibitors in cardiovascular disease [J]. Nat Rev Cardiol ,2012 ,9(7):402 -414.
  • 9Sun Y,Liu L,Han Y,Xu L,Zhang D,Wang H.The role of great auricular-facial nerve neurorrhaphy in facial nerve damage. Int J Clin Exp Med . 2015
  • 10Kmet TI,Tkachuk SS.Dynamics of changes of p53-positive cells morphofunctional condition in the cerebral cortex of the temporal lobe in rats affected by carotid ischemia-reperfusion. Patologicheskaia Fiziologiia i Eksperimental naia Terapiia . 2015

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部